Tag Archives: diabetes treatment adherence

Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits. Why do patients stop a therapy that clearly works? In many cases, the answer lies in a mix of side effects, cost, and patient expectations. This article explores early warning …

Why do so many patients begin treatment with good intentions, only to fall off track later? Staying consistent with diabetes treatment continues to challenge both patients and clinicians despite medical advances. While new therapies offer better control, long-term success still depends on consistency. However, many patients struggle to maintain routines, …

GLP-1 receptor agonists have transformed type 2 diabetes care. Yet for many patients, gastrointestinal side effects from GLP-1 therapy, such as nausea, vomiting, and constipation, can threaten long-term adherence. Have you ever had a patient achieve an impressive A1C reduction but consider stopping therapy because of persistent nausea? You are …